发明名称 EP4 receptor antagonists
摘要 A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R<SUP>2 </SUP>and R<SUP>5 </SUP>is: (i) H or an optionally substituted C<SUB>1-4 </SUB>alkyl group; or (ii)an optionally substituted C<SUB>5-7 </SUB>aryl; and the other of R<SUP>2 </SUP>and R<SUP>5 </SUP>is the other group; m and n can be 0 or 1, and m+n=1 or 2 R<SUP>N </SUP>is H or optionally substituted C<SUB>1-4 </SUB>alkyl R<SUP>3 </SUP>is either: (i) carboxy; (ii) a group of formula (II): (iii) a group of formula (III): wherein R is optionally substituted C<SUB>1-7 </SUB>alkyl, C<SUB>5-20 </SUB>aryl, or NR<SUP>N3</SUP>R<SUP>N4</SUP>, where R<SUP>N3 </SUP>and R<SUP>N4 </SUP>are independently selected from optionally substituted C<SUB>1-4 </SUB>alkyl; or (iv) tetrazol-5-yl.
申请公布号 US2005124676(A1) 申请公布日期 2005.06.09
申请号 US20040964831 申请日期 2004.10.15
申请人 CLARK DAVID E.;HARRIS NEIL V.;FENTON GARRY;HYND GEORGE;STUTTLE KEITH A.J.;SUTTON JONATHAN M.;OXFORD ALEXANDER W.;DAVIS RICHARD J.;COLEMAN ROBERT A.;CLARK KENNETH L. 发明人 CLARK DAVID E.;HARRIS NEIL V.;FENTON GARRY;HYND GEORGE;STUTTLE KEITH A.J.;SUTTON JONATHAN M.;OXFORD ALEXANDER W.;DAVIS RICHARD J.;COLEMAN ROBERT A.;CLARK KENNETH L.
分类号 A61K31/34;A61K31/41;C07D307/68;(IPC1-7):A61K31/34;C07D45/02 主分类号 A61K31/34
代理机构 代理人
主权项
地址